Cancer Care

 

 
An Extension Study of ABT-199 in Subjects with Advanced Non-Hodgkin's Lymphoma
Principal Investigator (?)
Study Number
F13143
Summary
This is a Phase 1, open-label, multicenter, extension study. Subjects with non-Hodgkin''s
lymphoma (NHL) (excluding chronic lymphocytic lymphoma [CLL], small lymphocytic lymphoma
[SLL], and mantle cell lymphoma [MCL]) who completed a prior ABT-199 study, or were active
and assigned to ABT-199 when the study was completed, may roll over into this extension
study. Subjects will receive ABT-199 during this study.
Phase (?)
Phase I
Sponsor (?)
Available at the following location(s)

Lebanon

View more details from ClinicalTrials.gov.

Contact Information

For more information about a clinical trial, clinical trial eligibility, or informed consent, contact our research nurses by phone or email:

Please Note: Any eligibility criteria noted are subject to change. Our research nurses can provide you with the most current eligibility and exclusion criteria. Any study involvement to be undertaken must ultimately be determined on an individual basis.